Jeffrey W. Albers Insider Trading $MGTA Magenta Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeffrey W. Albers.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeffrey W. Albers. Jeffrey W. Albers is CEO and President in Blueprint Medicines Corp ($BPMC) and Director in Magenta Therapeutics, Inc. ($MGTA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Jeffrey W. Albers in Magenta Therapeutics, Inc.

Trading Symbol: MGTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey W. Albers: Director
Holdings: 4,152 shares
Latest Transaction: Jun 09 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jeffrey W. Albers in Magenta Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BPMC, KYMR, MGTA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 09 2020MGTAMagenta Therapeuti ...Albers Jeffrey W.DirectorOption ExerciseA9.9918,188181,69818,188
Jun 11 2019MGTAMagenta Therapeuti ...Albers Jeffrey W.DirectorOption ExerciseA13.4018,188243,71918,188
Jun 27 2018MGTAMagenta Therapeuti ...Albers Jeffrey W.DirectorOption ExerciseC0.0010,72900
Jun 27 2018MGTAMagenta Therapeuti ...Albers Jeffrey W.DirectorBuyC0.004,15204,1520 to 4.2 K

Page:   1